These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9720446)

  • 21. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical assessment of prolonged therapy of patients with hypertension and diabetes with imidazoline receptor agonist moxonidine].
    Trusov VV; Aksenov KV; Filimonov MA
    Kardiologiia; 2002; 42(2):50-3. PubMed ID: 12494208
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients.
    Dupuy O; Bauduceau B; Mayaudon H
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):123S-126S. PubMed ID: 10921531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ACE-dependent and sympathetic components of blood pressure regulation in patients with essential hypertension].
    Aparina TV; Gomazkov OA; Dilakian EA; Britov AN
    Vopr Med Khim; 2001; 47(4):411-8. PubMed ID: 11693029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxonidine: a review of safety and tolerability after seven years of clinical experience.
    Schachter M
    J Hypertens Suppl; 1999 Aug; 17(3):S37-9. PubMed ID: 10489097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New discoveries in the regulation of arterial pressure: endazoline, rilmenidine and imidazoline receptors].
    Safar ME
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():9-10. PubMed ID: 2517010
    [No Abstract]   [Full Text] [Related]  

  • 28. Imidazoline I1 receptor agonists: new data on hypertension and related pathologies: introduction.
    Fernandez-Cruz A
    J Hypertens Suppl; 1997 Jan; 15(1):S1-2. PubMed ID: 9050979
    [No Abstract]   [Full Text] [Related]  

  • 29. New therapeutic agents for hypertension.
    Reid JL
    Br J Clin Pharmacol; 1996 Jul; 42(1):37-41. PubMed ID: 8807142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional studies of specific imidazoline-2 receptor ligands.
    Nutt DJ; French N; Handley S; Hudson A; Husbands S; Jackson H; Jordan S; Lalies MD; Lewis J; Lione L
    Ann N Y Acad Sci; 1995 Jul; 763():125-39. PubMed ID: 7677321
    [No Abstract]   [Full Text] [Related]  

  • 31. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Imidazoline receptors and use of drug blocking receptors I1].
    Lada W
    Pol Merkur Lekarski; 1996 Aug; 1(2):124-5. PubMed ID: 9156911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The 1989 Bichat Conference. A new therapeutic orientation in arterial hypertension: the action of rilmenidine (Hyperium 1 mg) on the so-called imidazoline receptors].
    Fillastre JP; Dhib M
    Rev Prat; 1990 Apr; 40(11):1032-3. PubMed ID: 2343243
    [No Abstract]   [Full Text] [Related]  

  • 35. Imidazolines stimulate release of insulin from RIN-5AH cells independently from I1- and I2-imidazoline receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Ann N Y Acad Sci; 1995 Jul; 763():374-6. PubMed ID: 7677349
    [No Abstract]   [Full Text] [Related]  

  • 36. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist.
    Kaaja R; Manhem K; Tuomilehto J
    Int J Clin Pract Suppl; 2004 Mar; (139):26-32. PubMed ID: 15117110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Curri G
    Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of imidazoline receptor agonist moxonidine on the state of microcirculation and renal function in patients with hypertension and diabetes mellitus type 2].
    Trusov VV; Aksenov KV
    Kardiologiia; 2003; 43(9):44-8. PubMed ID: 14682297
    [No Abstract]   [Full Text] [Related]  

  • 40. Involvement of I1-imidazoline receptors in mood disorders.
    Piletz JE; Halaris A
    Ann N Y Acad Sci; 1995 Jul; 763():510-9. PubMed ID: 7677367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.